Evidence map›Paper›PMID 23702428›Full record

ArticleBiological psychiatry2013

ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.

Stephanie E Daws, John D Whittard, Michelle M Jacobs, Yanhua Ren, Amin R Mazloom, Francesca F Caputi, Monika Horvath, Eva Keller, Avi Ma'ayan, Ying-Xian Pan and 2 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. ELK1 regulates BMPR1B transcriptional activity in ovine granulosa cells.Frontiers in cell and developmental biology · 2025
    Article
  8. OPRM1 Gene Polymorphism in Women with Alcohol Use Disorder.International journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Circular RNA regulation and function in drug seeking phenotypes.Molecular and cellular neurosciences · 2023
    Review
  12. Article
  13. Article
  14. Differential expression ofDrug and alcohol dependence reports · 2022
    Article
  15. Article
  16. Article
  17. Heroin Regulates Orbitofrontal Circular RNAs.International journal of molecular sciences · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Stephanie E DawsDepartments of Psychiatry and Neuroscience (SES, JDW, MMJ, YR, FFC, YLH); Department of Pharmacology and Systems Therapeutics (SES, MMJ, YR, ARM, FFC, AM, YLH), Ichan School of Medicine at Mount Sinai, New York, New York.
John D Whittard
Michelle M Jacobs
Yanhua Ren
Amin R Mazloom
Francesca F Caputi
Monika Horvath
Eva Keller
Avi Ma'ayan
Ying-Xian Pan
Lillian W Chiang
Yasmin L Hurd
Icahn School of Medicine at Mount Sinai · USJames J. Peters VA Medical Center · USMemorial Sloan Kettering Cancer Center · USPurdue Pharma (United States) · USSemmelweis University · HU

Funding

The Opioid mesolimbic system in heroin abuseR01DA015446 · NIDA · KAROLINSKA INSTITUTE · PI HURD, YASMIN L. · 2002 to 2018
$7.1M
Synthesis &Pharmacology of Novel Opiates and SystemsR01DA006241 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PAN, YING-XIAN · 1990 to 2018
$6.4M
TRAINING IN PHARMACOLOGY OF DRUGS OF ABUSET32DA007135 · NIDA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI DEVI, LAKSHMI A · 1985 to 2018
$4.9M
Characterizing exon 11 promoter of the mu opioid receptor gene, OPRMR01DA013997 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PAN, YING-XIAN · 2002 to 2012
$3.3M
The Mount Sinai Institute for NeuroAIDS DisparitiesR25MH080663 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2007 to 2015
$2.1M
Molecular Neurobiology of Human Drug AbuseR56DA015446 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HURD, YASMIN L. · 2019 to 2019
$564k
Exploring functions of mu opioid receptor carboxyl termini by gene targetingR21DA029244 · NIDA · SLOAN-KETTERING INST CAN RESEARCH · PI PAN, YING-XIAN · 2010 to 2011
$522k
NIDA NIH HHS DA013997NIDA NIH HHS DA015446NIDA NIH HHS R01 DA006241NIDA NIH HHS R01 DA013997NIDA NIH HHS R01 DA015446NIDA NIH HHS R21 DA029244NIDA NIH HHS R56 DA015446NIDA NIH HHS T32 DA007135NIDA NIH HHS T32DA007135NIMH NIH HHS R25 MH080663
6 · The paper itself

Abstract

backgroundAbuse of heroin and prescription opiate medications has grown to disturbing levels. Opioids mediate their effects through mu opioid receptors (MOR), but minimal information exists regarding MOR-related striatal signaling relevant to the human condition. The striatum is a structure central to reward and habitual behavior and neurobiological changes in this region are thought to underlie the pathophysiology of addiction disorders.

methodsWe examined molecular mechanisms related to MOR in postmortem human brain striatal specimens from a homogenous European Caucasian population of heroin abusers and control subjects and in an animal model of heroin self-administration. Expression of ets-like kinase 1 (ELK1) was examined in relation to polymorphism of the MOR gene OPRM1 and drug history.

resultsA characteristic feature of heroin abusers was decreased expression of MOR and extracellular regulated kinase signaling networks, concomitant with dysregulation of the downstream transcription factor ELK1. Striatal ELK1 in heroin abusers associated with the polymorphism rs2075572 in OPRM1 in a genotype dose-dependent manner and correlated with documented history of heroin use, an effect reproduced in an animal model that emphasizes a direct relationship between repeated heroin exposure and ELK1 dysregulation. A central role of ELK1 was evidenced by an unbiased whole transcriptome microarray that revealed ~20% of downregulated genes in human heroin abusers are ELK1 targets. Using chromatin immune precipitation, we confirmed decreased ELK1 promoter occupancy of the target gene Use1.

conclusionsELK1 is a potential key transcriptional regulatory factor in striatal disturbances associated with heroin abuse and relevant to genetic mutation of OPRM1.

Indexed as

AnimalsCorpus Striatumets-Domain Protein Elk-1FemaleHeroin DependenceHumansMaleNucleus AccumbensPolymorphism, GeneticRatsRats, Long-EvansReceptors, Opioid, muSignal TransductionELK1 protein, humanets-Domain Protein Elk-1OPRM1 protein, humanReceptors, Opioid, muAddictionMAPKopioidratself-administrationtranscriptome

Identifiers

PMID23702428
PMCPMC4070524
OpenAlexW2000825812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.